Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

  • Development of Rituximab-Resistant B-NHL Clones: An In Vitro Model for Studying Tumor Resistance to

    Development of Rituximab-Resistant B-NHL Clones: An In Vitro Model for Studying Tumor Resistance to

    Therapeutic strategies for cancer include chemotherapy, immunotherapy, and radia

    2025-03-14 38
  • The Prevention and Genetics of Pancreatic Cancer: A Programmatic Approach

    The Prevention and Genetics of Pancreatic Cancer: A Programmatic Approach

    Pancreatic cancer (PC) is typically a fatal disease due to its rapid growth and

    2025-03-14 43
  • MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Transloca

    MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Transloca

    Minimal residual disease (MRD) diagnostics is of high clinical relevance in pati

    2025-03-14 36
  • Circumventing Tumor Resistance to Chemotherapy by Nanotechnology

    Circumventing Tumor Resistance to Chemotherapy by Nanotechnology

    Patient relapse and metastasis of malignant cells is very common after standard

    2025-03-14 31
  • Mechanisms of Multidrug Resistance in Cancer

    Mechanisms of Multidrug Resistance in Cancer

    The development of multidrug resistance (MDR) to chemotherapy remains a major ch

    2025-03-14 30
  • Syngeneic Murine Metastasis Models: B16 Melanoma

    Syngeneic Murine Metastasis Models: B16 Melanoma

    Animal studies are costly, time consuming, and subject to several restrictive re

    2025-03-14 36
  • Establishment of Primary Cultures from Ovarian Tumor Tissue and Ascites Fluid

    Establishment of Primary Cultures from Ovarian Tumor Tissue and Ascites Fluid

    We have refined the technique for isolating and propagating cultures of primary

    2025-03-14 36
  • Tumor Markers in Screening for Ovarian Cancer

    Tumor Markers in Screening for Ovarian Cancer

    Tumor markers are used for multiple purposes in clinical care, including screeni

    2025-03-14 34
  • Real-Time Polymerase Chain Reaction of Immunoglobulin Rearrangements for Quantitative Evaluation of

    Real-Time Polymerase Chain Reaction of Immunoglobulin Rearrangements for Quantitative Evaluation of

    The evaluation of minimal residual disease (MRD) is critical in the evaluation o

    2025-03-14 35
  • An In Vitro Osteoclast-Forming Assay to Measure Myeloma Cell-Derived Osteoclast-Activating Factors

    An In Vitro Osteoclast-Forming Assay to Measure Myeloma Cell-Derived Osteoclast-Activating Factors

    Much of the morbidity and mortality associated with the plasma cell (PC) maligna

    2025-03-14 36
  • Analyzing Checkpoint Controls in Human Skin

    Analyzing Checkpoint Controls in Human Skin

    A short-term whole-skin organ culture model has been established to enable the i

    2025-03-14 37
  • Role of Cytokines in Pathology of Melanoma and Use of Biologic Response Modifiers in Melanoma

    Role of Cytokines in Pathology of Melanoma and Use of Biologic Response Modifiers in Melanoma

    Growth of normal cells is regulated by polypeptides that act via specific cellul

    2025-03-14 54
  • Mapping of Tumor Suppressor Genes in Ovarian Cancers

    Mapping of Tumor Suppressor Genes in Ovarian Cancers

    Although cancer is fundamentally a genetic disease, in the majority of cancers t

    2025-03-14 46
  • Detecting Mycoplasma Contamination in Cell Cultures by Polymerase Chain Reaction

    Detecting Mycoplasma Contamination in Cell Cultures by Polymerase Chain Reaction

    The detection of mycoplasmas in human and animal cell cultures is mandatory for

    2025-03-14 43
  • Measurement of Telomerase Activity in Human Hematopoietic Cells and Neoplastic Disorders

    Measurement of Telomerase Activity in Human Hematopoietic Cells and Neoplastic Disorders

    Telomeres are very important structures that protect chromosomal ends from recom

    2025-03-14 39